garenoxacin has been researched along with quinoline in 2 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (quinoline) | Trials (quinoline) | Recent Studies (post-2010) (quinoline) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 1,251 | 1 | 625 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deziel, MR; Drusano, GL; Liu, W; Louie, A; Tam, VH | 1 |
| Aubry, A; Chauffour, A; Escolano, S; Henquet, S; Jarlier, V; Matsuoka, M; Veziris, N | 1 |
2 other study(ies) available for garenoxacin and quinoline
| Article | Year |
|---|---|
The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Klebsiella pneumoniae; Microbial Sensitivity Tests; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2007 |
Resistance of M. leprae to quinolones: a question of relativity?
Topics: Animals; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Leprosy; Mice; Moxifloxacin; Mycobacterium leprae; Quinolines; Quinolones | 2013 |